Trials / Terminated
TerminatedNCT01483638
Axitinib as Maintenance Treatment in Patients With Metastatic CRC
A Phase II Study of Axitinib as Maintenance Treatment for Patients With Metastatic Colorectal Carcinoma
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the maintenance therapy with axitinib in patients with metastatic colorectal carcinoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | axitinib | 5 mg BID taken orally with food continuously on Day 1 of the study. One cycle corresponds to 28 days. |
| DRUG | placebo | will be administered orally with the same schedule of axitinib |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2011-12-01
- Last updated
- 2016-05-12
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01483638. Inclusion in this directory is not an endorsement.